You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mek162

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)

Active, not recruiting
  • Gastrointestinal Stromal Tumor (GIST)
  • MEK162
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 28, 2022

Low-Grade Gliomas, Malignant Tumors, Brain, Soft Tissue Tumors Trial in United States (MEK162)

Active, not recruiting
  • Low-Grade Gliomas
  • +2 more
  • MEK162
  • Birmingham, Alabama
  • +14 more
Jan 25, 2023

Solid Tumors Harboring a BRAF V600 Mutation Trial in Worldwide (LGX818, MEK162, LEE011)

Active, not recruiting
  • Solid Tumors Harboring a BRAF V600 Mutation
  • Tampa, Florida
  • +22 more
Mar 16, 2022

Gastrointestinal Stromal Tumor (GIST) Trial in New York (MEK162, Pexidartinib)

Completed
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 29, 2021

BRAF or NRAS Mutant Metastatic Melanoma Trial in Worldwide (MEK162)

Active, not recruiting
Has Results
  • BRAF or NRAS Mutant Metastatic Melanoma
  • MEK162
  • Fayetteville, Arkansas
  • +20 more
Nov 18, 2021

Advanced Biliary Tract Carcinoma Trial in New York (Gemcitabine, Cisplatin, MEK162)

Completed
Has Results
  • Advanced Biliary Tract Carcinoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 26, 2020

Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma Trial in Guangzhou (BYL719, INC280, LDK378)

Completed
Has Results
  • Adenocarcinoma Lung Cancer; Squamous Cell Lung Carcinoma
  • Guangzhou, Guangdong, China
    Novartis Investigative Site
Nov 20, 2020

Metastatic Colorectal Cancer Trial in Worldwide (MEK162, Panitumumab)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • Los Angeles, California
  • +7 more
Jan 27, 2021

Advanced Solid Tumor Trial in Nagoya-city, Yufu (MEK162)

Completed
  • Advanced Solid Tumor
  • MEK162
  • Nagoya-city, Aichi, Japan
  • +1 more
Sep 30, 2020

Cardiomegaly Trial in Boston, London (MEK162)

Withdrawn
  • Cardiomegaly
  • MEK162
  • Boston, Massachusetts
  • +1 more
Oct 2, 2020

Metastatic Melanoma Trial in Worldwide (LGX818, MEK162, Nivolumab)

Active, not recruiting
  • Metastatic Melanoma
  • Salzburg, AT, Austria
  • +29 more
Feb 23, 2022

Metastatic Pancreatic Adenocarcinoma, BRAF Mutated Melanoma Trial in Worldwide (MEK162, AMG 479)

Terminated
  • Metastatic Pancreatic Adenocarcinoma
  • BRAF Mutated Melanoma
  • MEK162
  • AMG 479
  • Boston, Massachusetts
  • +8 more
Dec 9, 2020

Hepatic Impairment Trial in United States (MEK162)

Terminated
  • Hepatic Impairment
  • MEK162
  • Lakewood, Colorado
  • +4 more
Sep 16, 2020

Uveal Melanoma Trial in Worldwide (AEB071, MEK162)

Terminated
Has Results
  • Uveal Melanoma
  • Boston, Massachusetts
  • +6 more
Sep 14, 2020

Melanoma Trial in Worldwide (LGX818, MEK162, LEE011)

Active, not recruiting
  • Melanoma
  • Los Angeles, California
  • +31 more
Jun 11, 2021

Locally Advanced or Metastatic NRAS Mutant Melanoma Trial in Worldwide (LEE011, MEK162)

Completed
Has Results
  • Locally Advanced or Metastatic NRAS Mutant Melanoma
  • San Francisco, California
  • +16 more
Nov 23, 2020

Solid Tumor and Hematologic Malignancies Trial in United States (MEK162)

Completed
Has Results
  • Solid Tumor and Hematologic Malignancies
  • MEK162
  • Mobile, Alabama
  • +67 more
Feb 2, 2021

Metastatic or Unresectable Cutaneous Melanoma Trial in Worldwide (MEK162, Dacarbazine)

Completed
Has Results
  • Metastatic or Unresectable Cutaneous Melanoma
  • Fayetteville, Arkansas
  • +228 more
Mar 18, 2021

Advanced and Selected Solid Tumors, AML, High Risk and Very High Risk MDS Trial in Worldwide (BYL719, MEK162)

Completed
  • Advanced and Selected Solid Tumors
  • +2 more
  • La Jolla, California
  • +15 more
Sep 29, 2017